Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2017) WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, 4th edn. IARC Press, Lyon
2. Braoudaki M, Papathanassiou C, Katsibardi K, Tourkadoni N, Karamolegou K (2010) The frequency of NPM1 mutations in childhood acute myeloid leukemia. J Hematol Oncol 3(1):41
3. Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM et al (2012) Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Ann Hematol 91(1):9–18
4. Krstovski N, Tosic N, Janic D, Lidija D, Milos K, Vesna S et al (2010) Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature. Med Oncol. 27(3):640–5
5. Haferlach C, Mecucci C, Schnittger S, Kohlmann A, Mancini M, Cuneo A et al (2009) AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biological, pathological, immunophenotypic, and prognostic features. Blood 114(14):3024–3032